Hege Charlotte Bakken
Director/Board Member at AUSTEVOLL SEAFOOD ASA
Net worth: 262 382 $ as of 2024-03-30
Profile
Hege Charlotte Bakken is currently the Deputy Chairman & Director at Austevoll Seafood ASA and a Director at Biomega Group AS.
She previously served as an Independent Director at Lerøy Seafood Group ASA, Director at Pronova BioPharma ASA, Director at Pronova Biopharma Norge AS, Director at Hofseth Biocare ASA, and Chief Operating Officer at Marvesa Rotterdam NV.
She also held the position of Chief Operating Officer at Marvesa Holding NV.
Bakken holds a graduate degree from the Norwegian University of Life Sciences and an MBA from ESCP Europe Campus London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SAGA PURE ASA
0.46% | 2022-12-30 | 2,211,580 ( 0.46% ) | 262 382 $ | 2024-03-30 |
Hege Charlotte Bakken active positions
| Companies | Position | Start |
|---|---|---|
| AUSTEVOLL SEAFOOD ASA | Director/Board Member | 2018-04-30 |
Biomega Group AS
 Biomega Group AS Pharmaceuticals: OtherHealth Technology Biomega Group AS manufactures and distributes fish byproducts. Its products include salmon meal and oil, and peptides+palatants. The company was founded in 2001 and is headquartered in Skogsvaegen, Norway. | Director/Board Member | 2023-01-31 |
Former positions of Hege Charlotte Bakken
| Companies | Position | End |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Director/Board Member | - |
Pronova Biopharma Norge AS
 Pronova Biopharma Norge AS Pharmaceuticals: MajorHealth Technology Pronova Biopharma Norge AS manufactures and supplies pharmaceutical products. The company is located in Norway. | Director/Board Member | - |
Marvesa Holding NV
 Marvesa Holding NV MiscellaneousMiscellaneous Part of Vlootbeheer BV, Marvesa Holding NV functions as an investment holding and Dutch financing company. The private company is based in Rotterdam, Netherlands. | Chief Operating Officer | - |
| HOFSETH BIOCARE ASA | Director/Board Member | - |
| Marvesa Rotterdam NV | President | - |
Training of Hege Charlotte Bakken
| Norwegian University of Life Sciences | Graduate Degree |
| ESCP Europe Campus London | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| LEROY SEAFOOD | Consumer Non-Durables |
| AUSTEVOLL SEAFOOD ASA | Consumer Non-Durables |
| HOFSETH BIOCARE ASA | Consumer Non-Durables |
| Private companies | 5 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
| Marvesa Rotterdam NV | |
Marvesa Holding NV
Marvesa Holding NV MiscellaneousMiscellaneous Part of Vlootbeheer BV, Marvesa Holding NV functions as an investment holding and Dutch financing company. The private company is based in Rotterdam, Netherlands. | Miscellaneous |
Pronova Biopharma Norge AS
Pronova Biopharma Norge AS Pharmaceuticals: MajorHealth Technology Pronova Biopharma Norge AS manufactures and supplies pharmaceutical products. The company is located in Norway. | Health Technology |
Biomega Group AS
Biomega Group AS Pharmaceuticals: OtherHealth Technology Biomega Group AS manufactures and distributes fish byproducts. Its products include salmon meal and oil, and peptides+palatants. The company was founded in 2001 and is headquartered in Skogsvaegen, Norway. | Health Technology |
- Stock Market
- Insiders
- Hege Charlotte Bakken
